
Chemicals: Is private equity getting the mix right?
While the alchemists of old never succeeded in turning lead into gold, private equity investors are seeing opportunities to profit from the chemicals sector. With a swathe of recent activity in the industry, including a major exit, chemicals companies are attracting significant interest from private equity funds. John Bakie investigates
In recent weeks, Barclays Private Equity-owned Konrad Hornschuch AG has made a significant purchase. Its acquisition of US-based O'Sullivan Films is the second add-on for the company since Barclays acquired the firm in a tertiary buyout in 2008.
While Hornschuch has, so far, been passed around by private equity investors, other firms are making successful exits in the sector. In March this year, BC Partners partially listed Brenntag AG, a global chemicals distributor, on the Frankfurt stock exchange, raising €747.5m.
BC Partners acquired the firm in 2006 from Bain Capital, in a transaction thought to be worth over €3.2bn. At the time of the deal, it was the largest LBO in Germany.
Private equity has also made an impact in restructuring firms weighed down by large debts.
In the case of LyondellBasell, Apollo Management has, this month, backed the debt restructuring of the chemicals giant. The deal, which saw $18bn of debt converted into equity, has allowed the company to emerge from Chapter 11 bankruptcy, which it had been in since January 2009. The firm is now hoping to put its troubles behind it, and plans to list on the New York Stock Exchange later this year.
Fortunes in the sector have been mixed, but growing demand for chemicals in a number of advanced applications, means there is scope for strong companies to find their place in the market.
Perhaps those medieval alchemists were on to something. While they were never going to make gold out of lead, the chemicals they were experimenting with, and the centuries of development since, have become attractive investments in the modern world.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater